Glucose Sensor Market Size, Trends, Shares, Insights and Forecast – 2018-2026

SEATTLE - July 15, 2021 - PRLog -- Glucose Sensor Market, by Product Type (Non-invasive (Optical Sensors and Transdermal Sensors), Invasive (Intravenous Implantable, Micro Dialysis, and Subcutaneous Sensor), and Minimally Invasive (Micro Pore/ Micro Needles)), by Technology (Polarimetry, Raman Spectroscopy, (Near) Infrared Spectroscopy, MIR Spectroscopy, Impedance Spectroscopy, Fluorescence, Photo-Acoustic Spectroscopy, Optical Coherence Tomography, Skin Suction Blister Technique, Sonophoresis, and Reverse Iontophoresis), by Distribution Channel (Hospitals, Clinics, Home Care Settings, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Glucose sensors are inserted under skin to measure glucose (sugar) levels. These sensors are connected wirelessly to the continuous glucose monitoring system. They offer data to the monitoring system or smart compatible devices that aid to track the level of blood glucose in a patient at regular intervals.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2490

Moreover, new product launches for measuring blood glucose levels is also expected to contribute to growth of the glucose sensor market size. For instance, in December 2018, Nemaura Medical Inc., a medical technology company developing sugarBEAT, signed licensing and distribution agreement with Doha-based Al-Danah Medical Co. to commercially launch sugarBEAT in Qatar by 2019. sugarBEAT is the first painless, non-invasive continuous glucose monitor (CGM) for use by diabetic and pre-diabetic patients.

North America is expected to witness significant growth in the glucose sensor market, owing to presence of major players and launch of new products in this region. For instance, in July 2018, Abbott Laboratories received the U.S. Food and Drug Administration (FDA) approval for its FreeStyle Libre 14 day Flash Glucose Monitoring System.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/glucose-sensor-market-2490

The systems eliminates the need for fingerstick testing by using a small sensor wire inserted below the skin's surface. This sensor continuously measures and monitors glucose levels.

Furthermore, Asia Pacific glucose sensor market is expected to witness significant growth over the forecast period, owing to increasing diabetes healthcare spending in the region. For instance, according to the International Diabetes Federation' (IDF) estimates, in 2017, diabetic healthcare spending in Asia Pacific was US$ 241 million.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2490